Baiyunshan And Huangpu Brand Ranking
If you want to improve the ranking of your company brand or wish to avoid appearing here, please contact trading@bossgoo.com.
Baiyunshan and Huangpu

Baiyunshan and Huangpu

Guangzhou Baiyunshan Pharmaceutical Holdings Co., Ltd.
If you want to improve the ranking of your company brand or wish to avoid appearing here, please contact trading@bossgoo.com.
Brand Introduction

Guangzhou Baiyunshan Hutchison Huangpu Traditional Chinese Medicine Co., Ltd. (hereinafter referred to as "Baiyunshan Hutchison Huangpu") was jointly established in May 2005 by the Baiyunshan Pharmaceutical Co., Ltd., a subsidiary of Guangzhou Pharmaceutical Group and Hutchison Huangpu (China) Company, a subsidiary of Mr. Li Ka-shing. The joint venture was formerly known as Guangzhou Baiyunshan Traditional Chinese Medicine Factory. It was established in May 1988. It was derived from the farm operation area established in 1956 and was transformed into a tonic factory that combines agriculture and industry, and then transformed into Guangzhou Baiyun, which operates the pharmaceutical and health industry. Shan Chinese Medicine Factory.

The company stands at the forefront of the times and the height of the industry, takes the cross policy of "education, love, technology, innovation, responsibility" as a guide, and takes the mission of "modernization of traditional Chinese medicine, internationalization of traditional Chinese medicine, popularization of traditional Chinese medicine, and popularization of traditional Chinese medicine" as its mission, and takes economic benefits. As the center, we focus on management internally, expand the market externally, and implement the three major strategies of "talent, brand, and technology", forming five core competitive advantages: scientific and technological innovation, responsible marketing, cultural heritage, talent engineering, and advanced party building. Especially since 1999, the company has entered a period of rapid growth and achieved leapfrog development. From 1999 to 2013, the scale of the enterprise expanded by 30 times, and the four indicators of sales, collection, output value and profit maintained a growth of more than 30%. The company actively builds a pioneer modern Chinese medicine enterprise and enters into advantageous enterprises in the big health industry.

Recommend Related Products

版权所有 © 宁波全贸信息技术有限公司 浙ICP备12012821号-1 浙B2-20200628

浙公网安备 33020902000078号